Bioqual Pre-Tax Profit Margin 2010-2023 | BIOQ

Bioqual pre-tax profit margin from 2010 to 2023. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
Bioqual Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2023-11-30 $0.06B $-0.00B -1.61%
2023-08-31 $0.06B 0 0.00%
2023-05-31 $0.06B $0.00B 1.59%
2023-02-28 $0.07B $0.00B 6.15%
2022-11-30 $0.07B $0.01B 10.29%
2022-08-31 $0.07B $0.01B 10.61%
2022-05-31 $0.07B $0.01B 10.77%
2022-02-28 $0.06B $0.00B 1.56%
2021-11-30 $0.06B $0.00B 1.67%
2021-08-31 $0.06B $0.00B 1.69%
2021-05-31 $0.06B $0.00B 1.69%
2021-02-28 $0.06B $0.01B 10.91%
2020-11-30 $0.05B $0.01B 11.11%
2020-08-31 $0.05B $0.01B 9.80%
2020-05-31 $0.05B $0.01B 10.87%
2020-02-29 $0.05B $0.02B 35.56%
2019-11-30 $0.04B $0.02B 37.21%
2019-08-31 $0.04B $0.02B 40.00%
2019-05-31 $0.04B $0.02B 60.00%
2019-02-28 $0.04B $0.02B 57.89%
2018-11-30 $0.04B $0.03B 80.56%
2018-08-31 $0.04B $0.04B 100.00%
2018-05-31 $0.04B $0.04B 100.00%
2018-02-28 $0.04B $0.04B 100.00%
2017-11-30 $0.04B $0.04B 100.00%
2017-08-31 $0.04B $0.04B 100.00%
2017-05-31 $0.04B $0.04B 100.00%
2017-02-28 $0.04B $0.04B 100.00%
2016-11-30 $0.04B $0.04B 100.00%
2016-08-31 $0.04B $0.04B 100.00%
2016-05-31 $0.03B $0.03B 100.00%
2016-02-29 $0.03B $0.03B 100.00%
2015-11-30 $0.03B $0.03B 100.00%
2015-08-31 $0.03B $0.03B 100.00%
2015-05-31 $0.03B $0.03B 100.00%
2015-02-28 $0.03B $0.03B 100.00%
2014-08-31 $0.02B $0.02B 100.00%
2014-05-31 $0.02B $0.02B 100.00%
2013-11-30 $0.02B $0.02B 100.00%
2013-08-31 $0.02B $0.02B 100.00%
2013-05-31 $0.02B $0.02B 100.00%
2012-05-31 $0.02B $0.02B 100.00%
2012-02-29 $0.02B $0.02B 100.00%
2011-11-30 $0.02B $0.02B 100.00%
2011-08-31 $0.02B $0.02B 100.00%
2011-05-31 $0.02B $0.02B 82.61%
2011-02-28 $0.04B $0.03B 88.57%
2010-11-30 $0.04B $0.03B 88.57%
2010-08-31 $0.04B $0.03B 88.57%
2010-05-31 $0.04B $0.03B 88.89%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.000B $0.063B
BIOQUAL, Inc., formerly Diagnon Corporation, develops, produces and sells diagnostic test kits incorporating monoclonal antibodies to diagnose certain anemias, infections, and parasitic diseases.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.537B 10.61
Quest Diagnostics (DGX) United States $15.695B 16.22
DaVita (DVA) United States $12.150B 15.09
Encompass Health (EHC) United States $8.507B 21.78
Chemed (CHE) United States $8.408B 26.06
Elanco Animal Health (ELAN) United States $8.297B 21.53
Option Care Health (OPCH) United States $5.048B 19.11
RadNet (RDNT) United States $4.325B 90.06
Amedisys (AMED) United States $3.145B 22.28
Astrana Health (ASTH) United States $2.239B 30.28
LifeStance Health (LFST) United States $2.179B 0.00
Addus HomeCare (ADUS) United States $1.827B 26.14
U.S Physical Therapy (USPH) United States $1.534B 41.06
Pennant (PNTG) United States $0.706B 37.29
Aveanna Healthcare Holdings (AVAH) United States $0.539B 0.00
Atai Life Sciences (ATAI) Germany $0.270B 0.00
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.026B 0.00
ATI Physical Therapy (ATIP) United States $0.021B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00